Our products in Europe

We provide generic injectable medicines in Europe and other markets around the world.

Related news

Hikma launches Benztropine Mesylate Injection, USP
24 March 2022
Hikma expands licensing agreement with Celltrion for Remsima® subcutaneous formulation in MENA
7 February 2022
Hikma launches Diazepam Injection, USP in single-dose prefilled syringe
21 January 2022

Last reviewed on 30 May 2022